KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Under the Medicare drug negotiations provisions in the reconciliation bill, the federal government would see its outlays reduced by about $300 billion. That reduction wouldn’t result from cuts in benefits. Instead, Medicare would be empowered to leverage its market power to pay lower prices for certain drugs.
In the first official test vote since the Supreme Court overturned Roe v. Wade, voters in Kansas’ primary said in no uncertain terms they want to keep a right to abortion in their state constitution. Meanwhile, the Senate is still working to reach a vote before summer recess on its health care-climate-tax measure, but progress is slow. Tami Luhby of CNN, Sandhya Raman of CQ Roll Call, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Bram Sable-Smith, who wrote the latest KHN-NPR “Bill of the Month” installment about a very expensive ambulance trip.
Measures to enshrine the right to abortion in the state constitution will be on the ballot in California and Vermont this fall. Abortion-rights advocates in Michigan are hoping their state will follow suit.
A ballot measure that would have taxed California millionaires to boost public health funding will not be on the November ballot. But the tech titans who bankrolled the effort say they are negotiating with Gov. Gavin Newsom’s administration to get more money without imposing new taxes.
President Joe Biden’s Cabinet members are fanning out across the country to promote benefits coming to rural America from covid relief and infrastructure legislation.
A KFF Health News database tracks campaign donations from drugmakers over the past 10 years.
Congress is set to start its once-every-five-years review of the law that authorizes user fees to finance the hiring of personnel to speed the FDA review of drugs. The periodic renewals of “PDUFA” also give lawmakers a chance to make other changes to the agency at the hub of the pandemic. Meanwhile, the FDA could also find itself at the center of the abortion debate and a controversial new medication to treat Alzheimer’s disease. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more.
Anti-vaccination activists say California’s Democratic lawmakers are helping strengthen their movement nationally by pushing for tougher vaccine requirements — without exemptions for religious or personal beliefs. But a new pro-vaccine lobbying force is vowing to fight back.
In the Nov. 8 general election, California voters will consider overturning the state’s flavored tobacco ban and hiking medical malpractice awards. Other proposals to decriminalize psychedelic mushrooms, target dialysis clinics and boost public health funding could also be on the ballot, along with a plan to limit business and school closures during public health emergencies.
Despite state Republican leaders’ rigid opposition to expanding the health program designed for low-income residents, advocates successfully gathered enough signatures to get the measure on the fall ballot.
Those seeking to replace California Gov. Gavin Newsom in Tuesday’s recall election disagree with him on more than mask and vaccine mandates. The conservative candidates tend to favor free-market solutions over Newsom’s expansion of publicly funded health coverage.
Democratic Gov. Gavin Newsom’s pandemic policies are effectively on California’s Sept. 14 recall ballot — and the electorate views them with a mix of resentment, gratitude and disillusionment.
KHN has teamed up with PolitiFact to track what becomes of President Joe Biden’s 2020 campaign promises over the next four years. As he moves into the West Wing, what are his chances of making progress on health care?
After spending tens of millions of dollars to oppose past efforts, Altria didn’t oppose Colorado’s tobacco tax initiative and could benefit from the law’s minimum-price provision.
President Donald Trump made substantial changes to the nation’s health care system using executive branch authority. But reversing policies that Democrats oppose would take time and personnel resources, competing with other priorities of the new administration.
Democrats are treating health care as a more critical issue than their Republican counterparts in Georgia’s two U.S. Senate runoffs. It’s a strategy they hope will woo independents and motivate base voters. The results will determine which party controls the chamber during the first years of the Biden administration.
Fears about lingering coronavirus at the White House are prompting a massive disinfection initiative before the Bidens move in.
Kent Thiry, the former CEO of dialysis giant DaVita, has clear ideas about how democracy should work. By backing ballot measures in Colorado, he’s shaping the power of voters in that state.
Over the past four years, the dialysis industry has spent $233 million on both political offense and defense in California. Most of it went toward protecting its revenues against ballot initiatives, but the industry also strategically worked the corridors of the state Capitol.